1.  Kumar NP, Kadar M, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Mohan N, Kornfeld H, Babu S. Heterogeneity in the cytokine profile of tuberculosis -diabetes co-morbidity. Cytokine, 2020;125:154824.                           

2.  Saranathan R, Sathyamurthi P, Kannan T, Murugesan S, Shivakumar SVBY, Gomathi NS, Kavitha D, Paradkar M, Puvaneshwari R, Kannan M, Madheswaran A, Pradhan N, Kulkarni V, Gupte AN, Gupte N, Vidya M, Bollinger RC, Gupta A,   Padmapriyadarsini C, Hanna LE; C-TRIUMPh study team. MAL adaptor (TIRAP) S180L polymorphism and tuberculosis disease severity among TB patients. Infection Genetics and Evolution, 2020;77:104093.                                                                    

3. Christe DM, Tamilselvi D, Surya S, Shobha S, Ponnuraja C. Vaginal deliveries in a tertiary centre: a current profile. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2020;9(1):134-139.                            

4. Vasanthamani P, Meenakshi S, Ponnuraja C, Padmanaban S. A study on perinatal outcome in oligohydramnios. International Journal of Clinical Obstetrics and Gynaecology 2020;4(1):39-41.                                                                            

5. Srimathi J, Sathya S, Padmanaban S. Low dose mifepristone in the conservative management of leiomyomas: A prospective randomised controlled trial. International Journal of Clinical Obstetrics and Gynaecology 2020;4(1):92-96.      
              
6. Muniyandi M, Thomas BE, Karikalan N, Kannan T, Rajendran K, Saravanan B, Vohra V, Okorosobo T, Lönnroth K, Tripathy SP. Association of tuberculosis with household catastrophic expenditure in south India. JAMA Network Open, 2020, 3(2):e1920973.    
                                                                                       
7.  Ashokumar M, Sonawane A, Sperk M, Tripathy SP, Neogi U, Hanna LE. In vitro  replicative fitness of early transmitted founder HIV-1 variants and sensitivity to  Interferon alpha. Scientific Reports, 2020;10(1):2747 & 13607. Publisher Correction incorporated and appeared online in August 2020.                         

8.  Sivasankaran MP, Hayes P, Fernandez N, Kannan T, Sathyamurthi P, Manohar N, Srinivasan A, Kathirvel S, Janani S, Goyal R, Singla N, Mukherjee J, Chatrath S, Gilmour J, Sudha S, Tripathy SP, Swaminathan S, Hanna LE. Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in      a phase I HIV-1 subtype C prophylactic vaccine trial in India. PLoS One, 2020;15(2):e0229461.

9.  Ashokkumar M, Sonawane A, Sathiyamani B, Esakialraj L BH, Hanna LE. An in vitro dataset on infectious potential of transmitted/founder (TF) and non-TF (NT)        HIV-1 viruses generated from Interferon alpha-treated primary CD4+ T cells. Data in Brief, 2020;29:105365.            

10. Kadar M, Pavan Kumar N, Ramalingam B, Banurekha VV, Dina N, Babu S. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment. Cytokine, 2020;127:154929.

 11.  Kumar TS, Josephine A, Sreelatha T, Azger Dusthackeer VN, Mahizhaveni B,     Dharani G, Kirubagaran R, Raja Kumar S. Fatty acids-carotenoid complex: An effective anti-TB agent from the chlorella growth factor-extracted spent biomass of          Chlorella vulgaris. Journal of Ethnopharmacology, 2020;249:112392.   

12. Shah I, Kumar Das S, Shetty NS, Kannan T, Ramachandran G, Hemanth Kumar AK.   Pharmacokinetics of isoniazid in children with tuberculosis - A comparative study at   two doses. Pediatric Pulmonology, 2020;55(3):660-665.                   

13. Anuradha R, Munisankar S, Dolla C, Menon PA, Nutman TB, Babu S. Helminth coinfection alters monocyte activation, polarization and function in latent Mycobacterium tuberculosis infection. Journal of Immunology, 2020;204(5):1274-   1286.                                                                                                              
14.   Sujitha K, Maheswaran M, Gopi Krishnan GK, Aiswarya S, Vijayalakshmi T,   Sivasankaran MP, Hanna LE, Manikannan M. Molecular characterization of enterococcus face-alis isolates from urinary tract infection and interaction between    enterococcus faecalis encountered dendritic and natural killer cells. Microbial   Pathogenesis, 2020;140:103944.                                                               

15.  Anuradha R, Munisankar S, Dolla C, Menon PA, Kannan T, Nutman TB, Babu S. Helminth infection modulates systemic pro-inflammatory cytokines and chemokines implicated in type 2 diabetes mellitus pathogenesis. PLoS Neglected Tropical Diseases, 2020;14(3):e0008101.                                                      

16.  Muniyandi M, Thomas BE, Karikalan N, Kannan T, Rajendran K, Dolla CK,   Saravanan B, Tholkappian AS, Tripathy SP, Swaminathan S. Catastrophic costs due   to tuberculosis in south India: comparison between active and passive case finding.      Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020; 114(3): 185-192.                                                                                                        
17.  Castor K, Mota FB, da Silva RM, Cabral BP, Maciel EL, de Almeida IN,    Arakaki-Sanchez D, Andrade KB, Testov V, Vasilyeva I, Zhao Y, Zhang H, Singh M, Rao R, Tripathy S, Gray G, Padayatchi N, Bhagwandin N,Swaminathan S, Kasaeva T, Kritski A. Mapping the tuberculosis scientific landscape among BRICS countries: A bibliometric and network analysis. Memorias Do Instituto Oswaldo Cruz, 2020;115: e190342.                                                                                                           

18.   Thomas BE, Chandra S, Lavanya J, Lindsley MM, Galivanche AT, Senthil S, Senthanro O, Amritha A, Savari L, Agnes LR, Kokila S, Javeed B, Arumugam S, Mayer KH, Swaminathan S, Ramnath S. Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India. BMJ Global Health, 2020;5(2):e001974.                                                            

19.  Ramesh Kumar S, Dolla CK, Vasantha M, Menon PA, Venkatsan G, Venkatesan P.    Strategies for smoking cessation (pharmacologic intervention versus enhanced   motivation vs. standard motivation) in TB patients under treatment in the RNTCP,          India - A cluster - Randomized trial. Indian Journal of Tuberculosis,2020;67(1):8-14.                                                                                                      
20.   Salhotra VS, Sachdeva KS, Khirsagar N, Parmar M, Ranjani R, Padmapriyadarsini C, Patel Y, Mehandru L, Jaju J, Ponnuraja C, Gupta M, Kalaiselvan V. Shamim A, Khaparde S, Swaminathan S, Bedaquiline CAP Sitge Teams. Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis. Indian Journal of Tuberculosis, 2020;67(1):29-37.                                                                                   

21. Gokul Raj K, Pavan Kumar N, Kadar M, Dina N, Banurekha VV, Sridhar R,   Baskaran D, Babu S. Matrix metalloproteinases and tissue inhibitors of   metalloproteinases are potential biomarkers of pulmonary and extra-pulmonary tuberculosis. Frontiers in Immunology, 2020;11:Article 419.                 

22.  Ramachandran G, Chandrasekaran P, Gaikwad S, Hemanth Kumar AK, Kannan T, Gupte N, Paradkar M, Dhanasekaran K, Gomathi NS, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V; Cohort for Tuberculosis Research by the Indo-US partnership (CTRIUMPh) team. Subtherapeutic Rifampicin concentration is associated with unfavourable tuberculosis   treatment outcomes. Clinical Infectious Diseases, 2020;70(7):1463-1470.

23.  Bhargavi G, Hassan S, Balaji S , Tripathy SP, Kannan P. Protein–protein interaction of Rv0148 with Htdy and its predicted role towards drug resistance in Mycobacterium tuberculosis. BMC Microbiology, 2020;20:93:10-15.                           
                                                                                                                                    
24.   Banurekha V, Jawahar MS, Dina N, Pooranagangadevi N, Ponnuraja C, Chandrasekaran K, Gomathi NS, Mahesh Kumar M, Kumaran PP, Ramesh Kumar S, Baskaran D, Devaleenal DB, Devarajulu RS, Vasantha M, Paramasivan P, Ramachandran G, Uma Devi KR, Hannah LE, Gomathi S, Radhakrishnan A, Kalaiselvi D, Dhanalakshmi A, Thiruvalluvan E, Raja Sakthivel M, Mahilmaran A, Sridhar R, Lavanya J, Prabhakaran R, Angamuthu P, Ponnusamy KS, Venkatesan P, Natrajan M, Tripathy SP, Swaminathan S. 4-month moxifloxacin containing regimens in the treatment of patients with sputum positive pulmonary tuberculosis in south India - a randomized clinical trial. Tropical Medicine and International Health, 2020;25(4):483-495.                                                                     

25. Gokul Raj K, Munisankar S, Banurekha VV, Dina N, Sridhar R, Babu S. Filarial coinfection is associated with higher bacterial burdens and altered plasma cytokine and chemokine responses in tuberculous lymphadenitis. Frontiers in Immunology, 2020;11:706.                                           
26.   Khusro A, Aarti C, Mahizhaveni B, Azger D, Agastian P, Esmail GA, Ghilan AM, Al- Dhabi NA, Arasu MV. Purification and characterization of anti-tubercular and   anticancer protein from Staphylococcus hominis strain MANF2: In silico structural and functional insight of peptide. Saudi Journal of Biological Sciences,   2020;27(4):1107-1116.
                                                                 
27. Anamika G, Pallavi S, Sunita R, Sivakumar S, Uma Devi KR, Shampa A, Vijay N. Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India. Indian Journal of Medical Research, 2020;151:361-370.                                          

28.  Anuradha R, Saravnan M, Dolla CK, Babu S. Diminished systemic and    mycobacterial antigen specific anti-microbial peptide responses in low body mass   index-latent tuberculosis co-morbidity. Frontiers in Cellular and Infection Microbiology, 2020;10:Article 165.                                    

29. Gokul Raj K, Kadar M, Sridhar R, Baskaran D, Babu S. Diminished systemic  levels of antimicrobial peptides in tuberculous lymphadenitis and their reversal after anti-tuberculosis treatment.  Tuberculosis (Edinb), 2020;122:101934.

30.  Gokul Raj K, Kadar M, Pavan Kumar N, Sridhar R, Baskaran D, Babu S. Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment. PLoS One, 2020;15(5): e0233426.                                   

31. Refaya AK, Bhargavi G, Noelin CM, Ananthi R, Radhika K, Swaminathan S, Kannan P. A review on bovine tuberculosis in India. Tuberculosis, 2020;122:101923.
                                                 
32.  Tornheim JA, Madugundu AK, Paradkar M, Fukutani KF, Queiroz ATL, Gupte N, Gupte AN, Kinikar A, Kulkarni V, Balasubramanian U, Sreenivasamurthy S, Raja R, Pradhan N, Shivakumar SVBY, Valvi C, Hanna LE, Andrade BB, Mave V, Pandey   A, Gupta A; CTRIUMPh RePORT India Study Team. Transcriptomic profiles of    confirmed pediatric tuberculosis patients and household contacts identifies active tuberculosis, infection, and treatment response among Indian children. The Journal of Infectious Diseases, 2020;221(10):1647-1658.                                    

33. Nancy Hilda J, Sulochana D, Tripathy SP, Hanna LE. Editor’s choice. Role of neutrophils in tuberculosis: A bird's eye view. Innate Immunity, 2020;26(4):239. Role of neutrophils in tuberculosis: A bird's eye view. Innate Immunity, 2020;26(4):240-247. 

34. Muniyandi M, Karikalan N, Kannan T, Saravanan B, Vidhya P, Rajendran K. TB diagnostic cascade among patients registered under the Revised National TB control programme in Chennai, south India. Tropical Medicine and International Health,           2020;25(5):612-617.                                                                                   

37.  Zacharias L, Thomas PT, Warrier GM, Adhin B, Saraswathi N, Seena V, Kiran P, Preethish K, Ravi Y, Suvarna A, Nalini A, Pal PK. Palliative care needs and care giver burden in neurodegenerative diseases: A cross-sectional study. Annals of Indian Academy of Neurology, 2020;23(3):313-317.                                   

38.  Radha G, Sivakumar S, Rajesh M, Selvakumar S. Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment. Journal of Biomedical Science, 2020;27:74.                      

39.  Manohar Nesakumar S, Hemalatha H, Vidya Vijayan KK, Precilla LK, Ramesh K, Murugavel KG, Tripathy SP, Hanna LE. Genetic characterization of full-length HIV- 2 long terminal repeat sequences: Identification of rare promoter variants. AIDS           Research and Human Retroviruses, 2020;36(6):533-538.                       

40.  Azger D, Shainaba AS, Manonanthini T, Sameer H, Mahizhaveni B, Angayarkani B, Ramachandran G, Hemanth Kumar AK, Kannan T, Govindarajan S, Christy RN, Ebenezer RS, Sucharitha KM, Rajesh M. Wild-type MIC distribution for re-evaluating the critical concentration of anti-TB drugs and pharmacodynamics  among tuberculosis patients from south India. Frontiers in Microbiology, 2020; 11:Article 1182.                 
                                                                           
41.  Adhin B, Ponnuraja C, Srinivasan R, Padmanaban S. Distribution and growth rate of COVID‑19 outbreak in Tamil Nadu: A log‑linear regression approach. Indian Journal of Public Health, 2020;64(Supplement 2):S188-S191.                                  

42.  Roma Haresh P, Vivek G, Pramila S, Madhur V, Sabira S, Reeta Y, Homa M, Stobdan K, Sriram S, Mrinalini D, Chinmay L, Gabriella F, Petros I. Yield of systematic longitudinal screening of household contacts of pre-extensively drug resistant (PreXDR) and extensively drug resistant (XDR) tuberculosis patients in Mumbai, India. Tropical Medicine and Infectious Diseases, 2020;5(2):83.

43. Subramaniam D, Hanna LE, Maheshkumar K, Ponmurugan K, Al-Dhabi NA, Murugan P. Immune stimulatory and anti-HIV-1 potential of extracts derived from marine brown algae Padina tetrastromatica. Journal of Complementary and Integrative Medicine, 2020;17(2):Article number: 20190071.       

44. Kim HY, Srivastava S, Hemanth Kumar AK, Marais BJ, Alffenaar JW. Optimal dose or optimal exposure? Consideration for Linezolid in tuberculosis treatment. Antimicrobial Agents and Chemotherapy, 2020; 64(7):e00287.         

45.  Oliveira-de-Souza D, Vinhaes CL, Arriaga MB, Pavan Kumar N, Queiroz ATL, Fukutani KF, Babu S, Andrade BB. Aging increases the systemic molecular degree ofinflammatory perturbation in patients with tuberculosis. Scientific Reports, 2020; 10: 11358.                                                                                    

46. Srinivasan K, Kannan P, Gupta UD, Narayanan S. Double deletion of PknI/DacB2  leads to attenuation of Mycobacterium tuberculosis for growth and virulence.   Tuberculosis, 2020;123:101957.                                                               

47. Paradkar M, Padmapriyadarsini C, Divyashri J, Shivakumar SVBY, Kannan T, Gupte AN, Thomas BE, Aarti Kinikar, Krithika S, Bharadwaj R, Dolla CK, Gaikwad S, S. Elilarasi, Rahul L, Devarajulu Reddy, Lakshmi M, Kulkarni V, Neeta P, Hanna LE, Sathyamurthi P, Kohli R, Rani S, Nishi Suryavanshi, Shrinivasa BM, Cox SR Sriram S,  Nikhil Gupte, Mave V, Gupta A, Bollinger RC, for the CTRIUMPH-RePORT India study team. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS One. 2020; 15(7):e0236743.                  
                                                           
48.   Thomas  BE, Kumar JV, Onongaya C, Bhatt SN, Amith G, Murugesan P, Chiranjeevi M, Amit Subhash K, Ramachandran G, Daksha S, Haberer JE, Kenneth KH, Subbaraman R. Explaining differences in the acceptability of 99DOTS, a cell phone–based strategy for monitoring adherence to tuberculosis medications: Qualitative study of patients and health care providers. JMIR MHealth and Uhealth, 2020;8(7):e16634. 
                                                                                                           
49.  Prathiksha G, Elilarasi S, Sarath B, Pramila SK, Arunagirinathan V, Sivakumar S, Syed Hissar, Mohan N, Dooley KE, Bella Devaleenal D. Drug resistant TB spine in a two year old child: A case report. Indian Journal of Tuberculosis, 2020;67(3):374-377. 

50.  Narendran G, Keerthana J, Thirumaran S, Vinhaes CL, Santhanakrishnan RK, Tamizhselvan M, Anbhalagan S, Padmapriyadarsini C, Menon PA, Bhavani PK, Devarajulu Reddy, Ravichandran N, Balaji S, Sekhar S, Raja K, Pownraj K, Dhanalakshmi A, Stella Mary S, Ganesan RRK, Tripathy SP, Swaminathan S, Andrade BB. Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV. International Journal of Infectious Diseases, 2020;98:261–267.                                                                  

51. Balaji S, Gomathi S, Devi Sangamithrai, Rajkumar R, Kannan T, Vaishnavi V, Ayswarya S, Tripathy SP, Rajesh M. Reprocessing of contaminated MGIT 960 cultures to improve availability of valid results for mycobacteria. International Journal of Microbiology, 2020; Article ID 1721020.                                      

52.  Balaji S,  Gomathi S, Rajaram D,  Devi Sangamithrai, Sivaraman P , Dinesh V , Kannan T, Golla R,  Nagarajan P,  Rajesh M.  Improved detection of previously undetectable mycobacteria grown in liquid culture. International Journal of Tuberculosis and Lung Diseases, 2020;24(7):754-755.                        

53. Preeti M, Raman K, Adhin Bhaskar. Effectiveness of a Nurse-Led Intervention for Adolescents With Problematic Internet Use. Journal of Psychosocial Nursing and Mental Health Services, 2020;58(7):16-26.                                       

54.  Murhekar MV, Tarun Bhatnagar, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, Kumar MS, Shah N, Sabarinathan R, Turuk A, Anand PK, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chakraborty D, Rangaraju C, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Salim Khan SM, Haq I, Kumar MS, Laxmaiah A, (Major) Madhukar, Mahapatra A, Mitra A, Nirmala AR, Pagdhune A, Qurieshi MA, Ramarao T, Sahay S, Sharma YK, Shrinivasa MB, Shukla VK, Singh PK, Viramgami A, Wilson VC, Yadav R, Girish Kumar CP, Hanna LE, Uma Devi R , Babu S, Sekar K, Yadav PD, Sapkal GN, Das A, Das P, Dutta S, Hemalatha R, Kumar A, Narain K, Narasimhaiah S, Panda S, Sanghamitra Pati, Shripad Patil, Sarkar K, Shalini Singh, Rajni Kant, Tripathy S, Toteja GS, Babu GR, Shashi Kant, Muliyil JP, Pandey RM, Swarup Sarkar, Singh SK, Zodpey S, Gangakhedkar RR, Reddy DCS, Bhargava B. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian Journal of Medical Research, 2020;152(1&2):48-60.    
                                                                                
55.  Gokul Raj K, Sridhar R, Baskaran D, Babu S. Low body mass index has minimal  impact on plasma levels of cytokines and chemokines in tuberculous lymphadenitis Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2020;20:100163.
                                                                                                                       
56.  Kalra A, Parija D, Raizada N, Sachdeva KS, Raghuram Rao, Swaminathan S, Khanna A, Chopra KK, M. Hanif M, Varinder Singh, Umadevi KR, Sheladia KN, Rama Rao, Vasundhara N, Anil S, Nirmala AR, Azeem A, Chhajlani V, Khurana J, Das NJ, Bandana Choudhury, Nair SA, Shalini Mall, Rajashree Sen, Chadha SS, Denkinger CM, Boehme C, Sarin S. Upfront Xpert MTB/RIF or diagnosis of pediatric TB — Does it work? Experience from India. PLoS One, 2020;15(8):e0236057.

57.  Anuradha R, Saravanan M, Menon PA, Dolla CK, Nutman TB, Babu S. Helminth mediated attenuation of systemic inflammation and microbial translocation in helminth-diabetes co-morbidity. Frontiers in Cellular and Infection Microbiology, 2020; 10: Article 431.                                         

58.  Anuradha R, Saravanan M, Kannan T, Menon PA, Dolla CK, Nutman TB, Babu S. Impact of helminth infection on metabolic and immune homeostasis in non-diabetic obesity. Frontiers in Immunology, 2020;11:Article 2195.                      

59.   Gokul Raj K, Kadar M,  Sridhar R, Baskaran D, Babu S. Diminished frequencies of cytotoxic marker expressing T- and NK cells at the site of Mycobacterium tuberculosis infection. Frontiers in Immunology, 2020;11:Article 585293.

60. Karikalan N, Muniyandi M, Bharathidasan P, Senthil S. Social network analysis methods for exploring SARS-CoV-2 contact tracing data. BMC Medical Research Methodology, 2020;20:233.                                                              

61.   Pavan Kumar N, Gokul Raj K, Kadar M, Banurekha VV, Dina N, Fay MP, Nutman TB, Babu S. Strongyloides stercoralis coinfection is asssociated with greater disease severity, higher bacterial burden, and elevated plasma matrix metalloproteinases in pulmonary tuberculosis. The Journal of Infectious Diseases, 2020;222:1021-1026.

62.  Sarah Helfinstein, Elisabeth Engl, Thomas BE, Gayathri N, Prithivi P, Mokshada J, Lavanya J, Murugesan J, Rebekah C, Tichakunda M, Hannah K, Shamim M, Dabas H, Charles GK, Sgaier SK. Understanding why at-risk population segments do not seek care for tuberculosis: a precision public health approach in south India. BMJ Global Health, 2020;5(9):e002555.                                                           
63.   Radha G, Natarajan G, Kalamani V, Aravindhan V, Selvakumar S. The strange case of BCG and COVID-19: The verdict is still up in the air. Vaccines (Basel), 2020;8(4): E612.                                                                                                            

64.   Siva Kumar S, Ashok Kumar S, Gomathi S, Devika K, Bhasker M, Sriram S, Dolla CK, Menon PA, Tripathy SP, Narayanan PR, Uma Devi R, Narayanan S, Mondal R. Spoligotype diversity of Mycobacterium tuberculosis over two decades from Tiruvallur, south India. International Journal of Microbiology, 2020;Article ID 8841512.                                                                                   

65. Gomathi NS, Manjula Singh, Singh UB, Myneedu VP, Chauhan DS, Rohit Sarin, Anant Mohan, Anuj Bhatnagar, Jiten Singh Khangembam, Kannan T, Rao MVV, Jyoti Logani, Bindu Dey, Gangakhedkar RR, Swaminathan S, Tripathy S, for Task Force on TB Diagnostics. Multicentric validation of indigenous molecular test Truenat™ MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards. Indian Journal of Medical Research, 2020; 152(4):378–385.           

66.  Banurekha V, Lavanya J, Basilea W, Saraswathy J, Dhanalakshmi A, Priscilla R, Bella Devaleenal D, Dina N, Tripathy S, Sriram S. Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting. PLoS One, 2020;15(10):e0240594.                                                             

67. Gomathi NS, Manjula Singh, Myneedu VP, Chauhan DS, Tripathy S, Rohit Sarin, Anant Mohan, Anuj Bhatnagar, Jiten Singh Khangembam, Kannan T, Rao MVV, Jyoti Logani, Bindu Dey, Gangakhedkar RR, Swaminathan S, Singh UB. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients. Indian Journal of Medical Research, 2020;152(5):482–489.                               

68. Kornfeld H, Sahukar SB, Procter-Gray E, Pavan Kumar N, West K, Kane K, Mohan N, Li W, Babu S, Vijay V. Impact of diabetes and low body mass index on tuberculosis treatment outcomes. Clinical Infectious Diseases, 2020;71(9):e392-e398.                                                                                                         
69.  Rohini D, Chowdhury RR, Kavyashree M, Hanna LE, Raghavan V. A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing. Proceedings of the National Academy of Sciences, 2020;117(47):29584-29594.                                                                                               
70. Anuradha R, Saravanan M, Dolla CK, Kannan T, Babu S. Impact of malnutrition on systemic immune and metabolic profiles in type 2 diabetes. BMC Endocrine Disorders, 2020;20:168.                                                            

71.  Ashokkumar M, Sathyamurthi P, Tripathy SP, Neogi U, Hanna LE. Deep profiling identifies selection of nonsynonymous amino acid substitutions in HIV-1 envelope during early infection. AIDS Research and Human Retroviruses, 2020;36(12):1024–1032.                                              

72.  Barik SK, Mohanty KK, Mohanty AK, Preeti R, Gopal G, Deepa Bisht, Patil SA, Rananjay S, Devesh S, Tripathy SP, Rekha T, Singh TP, Srikanta J. Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy. BMC Infectious Diseases, 2020; 20: 898.                                                                                    
73. Sivakumar S, Yuvaraj C, Gokul Raj K, Gomathi S, Devika K, Venkatesan P, Syed Hissar, Tripathy SP, Ramalingam B, Baskaran D, Babu S, Uma Devi KR. The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in south India. BMC Infectious Diseases, 2020;20:894. 

74. Krisna Moorthi P, Uma Devi R, Tripathy SP, Ramalingam B. Vitamin D – A host directed autophagy mediated therapy for tuberculosis. Molecular Immunology, 2020; 127:238–244.                                                                                           

75.  Thomas BE, Vignesh Kumar J, Chiranjeevi M, Daksha Shah, Khandewale A, Kannan T, Haberer JE, Mayer KH, Ramnath S. Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: Comparison of digital adherence data with urine Isoniazid testing. Clinical Infectious Diseases, 2020;71(9):e513–516.                                                    
76. Pawde DM, Viswanadh MK, Mehata AK, Sonkar R, Narendra, Suruchi P, Burande AS, Jha A, Vajanthri KY, Mahto SK, Azger Dustakeer VN, Muthu MS. Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis. Saudi Pharmaceutical Journal, 2020;28(12): 1616–1625.  

77. Su Yadana, Talegawkar SA, Mathad JS, Mallika A, Kripa R, Pavan Kumar N, Shilpa N, Leu CS, Vandana K, Prasad D, Mariana AP, Ramesh B, Babu S,  Andrade BB, Caulfield LE, Amita G, Shivakoti R. Association of vegetable and animal flesh intake with inflammation in pregnant women from India. Nutrients, 2020;12(12):3767.
 
78.  Pavan Kumar N, Kadar M, Arul Nancy, Vijay V, Kannan T, Sivakumar S, Syed Hissar, Dina N, Banurekha VV, Kornfeld H, Babu S. Association of plasma matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase levels with adverse treatment outcomes among patients with pulmonary tuberculosis. JAMA Network Open, 2020;3(12):e2027754.                            

79.  Padmapriyadarsini C, Sekar L, Devarajulu Reddy, Anandha Chitra, Poornagangadevi N, Selvaraj M, Bhavani PK, Mothi SN, Nandagopal K, Vennila S, Tamizhselvan M, Maheshmanisha J, Upasna Agarwal, Rewari BB, Swaminathan S. Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting. Indian Journal of Medical Research, 2020;152(6):648–655.

80.  Radhakrishna S. Tuberculosis Chemotherapy Centre - The beginning. Indian Journal of Tuberculosis, 2020;67(4):Supplement S3-S6.                               

81.  National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), ICMR-NIRT, Chennai and Srikanth Tripathy. Tuberculosis research conducted over the years at the ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT). Indian Journal of Tuberculosis, 2020;67(4):Supplement S7-S15.                                                                                                                
82.  Harishankar M, Pavithra S, Athikesavan V, Ponnuraja C, Banurekha VV, Uday Kumar P, Tripathy SP, Uma Devi R, Selvaraj P, Ramalingam B. Association of rs7041 and rs4588 gene polymorphisms of vitamin D binding protein gene in pulmonary tuberculosis. Meta Gene, 2020;26:100822.                                     

83. Adhin B and Chinnaiyan P. Comparison of regression models for binary outcome variables in clinical trials. Current Science, 2020;119(12):2010-2013.

84.  Premalatha PB, Ponnuraja C, Padmanaban S, Adhin B, Palaniyandi P. Oligohydramnios and its perinatal outcome in a tertiary hospital. International Journal of Clinical Obstetrics and Gynaecology 2020; 4(6): 227-228.